|
|
|
Insider
Information: |
Pops Richard F |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
1,301,687 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$38,585,989 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,301,687 |
|
|
Total
Value |
$38,585,989 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-03-13 |
29,512 |
2005-11-23 |
0 |
Premium* |
|
Alkermes Plc |
ALKS |
Director and CEO, Alke... |
2024-02-08 |
1,179,675 |
2011-09-16 |
0 |
Premium* |
|
Epizyme, Inc. |
EPZM |
Director |
2013-05-30 |
60,000 |
|
0 |
Premium* |
|
Acceleron Pharma Inc |
XLRN |
Director |
2019-01-25 |
32,500 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
257 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2019-09-19 |
4 |
OE |
$9.21 |
$921,000 |
D/D |
100,000 |
816,433 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2019-11-07 |
4 |
OE |
$9.21 |
$642,812 |
D/D |
69,795 |
786,228 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2019-11-08 |
4 |
OE |
$9.21 |
$278,188 |
D/D |
30,205 |
746,638 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2013-01-14 |
4 |
OE |
$9.97 |
$498,500 |
D/D |
50,000 |
471,047 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2013-01-22 |
4 |
OE |
$9.97 |
$498,500 |
D/D |
50,000 |
471,047 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2013-02-19 |
4 |
OE |
$9.97 |
$498,500 |
D/D |
50,000 |
471,047 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2013-02-25 |
4 |
OE |
$9.97 |
$162,013 |
D/D |
16,250 |
437,297 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2013-03-28 |
4 |
OE |
$10.60 |
$127,200 |
D/D |
12,000 |
12,000 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2020-03-19 |
4 |
OE |
$11.74 |
$880,500 |
D/D |
75,000 |
834,094 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2020-03-26 |
4 |
OE |
$11.74 |
$880,500 |
D/D |
75,000 |
834,094 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2020-04-02 |
4 |
OE |
$11.74 |
$587,000 |
D/D |
50,000 |
809,094 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2020-05-07 |
4 |
OE |
$11.74 |
$587,000 |
D/D |
50,000 |
809,094 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2020-05-14 |
4 |
OE |
$11.74 |
$880,500 |
D/D |
75,000 |
834,094 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2013-03-28 |
4 |
D |
$12.15 |
$127,198 |
D/D |
(10,469) |
1,531 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2013-07-01 |
4 |
OE |
$12.16 |
$1,336,500 |
D/D |
100,000 |
483,916 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2013-07-08 |
4 |
OE |
$12.16 |
$1,336,500 |
D/D |
100,000 |
483,916 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2013-08-05 |
4 |
OE |
$12.16 |
$1,331,036 |
D/D |
99,625 |
533,541 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2013-08-12 |
4 |
OE |
$12.16 |
$414,960 |
D/D |
34,125 |
468,041 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2018-05-01 |
4 |
OE |
$12.29 |
$614,500 |
D/D |
50,000 |
716,352 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2018-05-08 |
4 |
OE |
$12.29 |
$614,500 |
D/D |
50,000 |
716,352 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2018-05-15 |
4 |
OE |
$12.29 |
$614,500 |
D/D |
50,000 |
716,352 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2018-05-22 |
4 |
OE |
$12.29 |
$245,800 |
D/D |
20,000 |
686,352 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2014-06-18 |
4 |
OE |
$12.30 |
$615,000 |
D/D |
50,000 |
570,063 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2014-07-02 |
4 |
OE |
$12.30 |
$615,000 |
D/D |
50,000 |
570,063 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2014-05-12 |
4 |
OE |
$12.37 |
$148,440 |
D/D |
12,000 |
13,531 |
0 |
- |
|
257 Records found
|
|
Page 4 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|